The one exception involves ultra-low temperature storage at negative 80 degrees Celsius using specialized aliquoting techniques
Injection site reactions, unusual bruising, or unexpected lack of appetite suppression after injection may indicate you received a degraded dose, though other factors can cause these effects
If a patient receives a dosage significantly higher than advised, serious side effects like renal failure or blood poisoning may manifest
The C18 fatty di-acid moiety, attached at Lys-26 via a Glu2OEG (2AEEA) linker, enables reversible binding to serum albumin at physiological concentrations, sequestering the peptide in a circulating depot that is both protected from clearance and slowly released to engage the GLP-1 receptor
Some individuals notice appetite changes within the first few weeks, while measurable weight loss often occurs over several months
Fifty-eight per cent of people taking or considering taking GLP-1 drugs said weight loss was their main driver, while 42 per cent said diabetes was their primary reason